CN101603026B - Animal-source-free low-protein medium suitable for production of animal cell products - Google Patents
Animal-source-free low-protein medium suitable for production of animal cell products Download PDFInfo
- Publication number
- CN101603026B CN101603026B CN2009100535068A CN200910053506A CN101603026B CN 101603026 B CN101603026 B CN 101603026B CN 2009100535068 A CN2009100535068 A CN 2009100535068A CN 200910053506 A CN200910053506 A CN 200910053506A CN 101603026 B CN101603026 B CN 101603026B
- Authority
- CN
- China
- Prior art keywords
- animal
- sodium
- acid
- culture medium
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 21
- 210000004102 animal cell Anatomy 0.000 title abstract description 20
- 241001465754 Metazoa Species 0.000 claims abstract description 17
- 239000001963 growth medium Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 8
- 239000011790 ferrous sulphate Substances 0.000 claims abstract description 8
- 235000003891 ferrous sulphate Nutrition 0.000 claims abstract description 8
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical group [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims abstract description 8
- 229910000359 iron(II) sulfate Inorganic materials 0.000 claims abstract description 8
- -1 lipid compounds Chemical class 0.000 claims abstract description 7
- 229940088594 vitamin Drugs 0.000 claims abstract description 7
- 229930003231 vitamin Natural products 0.000 claims abstract description 7
- 235000013343 vitamin Nutrition 0.000 claims abstract description 7
- 239000011782 vitamin Substances 0.000 claims abstract description 7
- 229940088597 hormone Drugs 0.000 claims abstract description 6
- 239000005556 hormone Substances 0.000 claims abstract description 6
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 6
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 6
- 239000007793 ph indicator Substances 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 239000006174 pH buffer Substances 0.000 claims abstract description 5
- 239000012153 distilled water Substances 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 230000004060 metabolic process Effects 0.000 claims abstract 3
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 16
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims description 16
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims description 14
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 14
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 10
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 10
- 235000010469 Glycine max Nutrition 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 8
- 239000005700 Putrescine Substances 0.000 claims description 8
- 229960000890 hydrocortisone Drugs 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 244000068988 Glycine max Species 0.000 claims description 7
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 7
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 7
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- 239000000186 progesterone Substances 0.000 claims description 7
- 229960003387 progesterone Drugs 0.000 claims description 7
- 229940011671 vitamin b6 Drugs 0.000 claims description 7
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 229930003779 Vitamin B12 Natural products 0.000 claims description 6
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 6
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 6
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 6
- 235000019163 vitamin B12 Nutrition 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 5
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 5
- 239000004475 Arginine Substances 0.000 claims description 5
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 5
- 235000019743 Choline chloride Nutrition 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000004471 Glycine Substances 0.000 claims description 5
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 5
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 5
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical group C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims description 5
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 5
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 claims description 5
- 229960002079 calcium pantothenate Drugs 0.000 claims description 5
- 235000012000 cholesterol Nutrition 0.000 claims description 5
- 229960003178 choline chloride Drugs 0.000 claims description 5
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 5
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 5
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 5
- 229960000367 inositol Drugs 0.000 claims description 5
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 5
- MVFCKEFYUDZOCX-UHFFFAOYSA-N iron(2+);dinitrate Chemical compound [Fe+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MVFCKEFYUDZOCX-UHFFFAOYSA-N 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- 235000019136 lipoic acid Nutrition 0.000 claims description 5
- 229930182817 methionine Natural products 0.000 claims description 5
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims description 5
- 229920000570 polyether Polymers 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 235000019192 riboflavin Nutrition 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 239000002151 riboflavin Substances 0.000 claims description 5
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 5
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 5
- 239000011781 sodium selenite Substances 0.000 claims description 5
- 235000015921 sodium selenite Nutrition 0.000 claims description 5
- 229960001471 sodium selenite Drugs 0.000 claims description 5
- 229960003080 taurine Drugs 0.000 claims description 5
- 229960002663 thioctic acid Drugs 0.000 claims description 5
- 229940104230 thymidine Drugs 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 5
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 5
- 229960001763 zinc sulfate Drugs 0.000 claims description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 229960001230 asparagine Drugs 0.000 claims description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 4
- 229960002885 histidine Drugs 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 4
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 229960001295 tocopherol Drugs 0.000 claims description 4
- 235000010384 tocopherol Nutrition 0.000 claims description 4
- 239000011732 tocopherol Substances 0.000 claims description 4
- 229930003799 tocopherol Natural products 0.000 claims description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 235000011148 calcium chloride Nutrition 0.000 claims description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 229960003136 leucine Drugs 0.000 claims description 2
- 102000002070 Transferrins Human genes 0.000 claims 3
- 108010015865 Transferrins Proteins 0.000 claims 3
- 150000002505 iron Chemical class 0.000 claims 3
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims 2
- KGWDUNBJIMUFAP-KVVVOXFISA-N Ethanolamine Oleate Chemical compound NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O KGWDUNBJIMUFAP-KVVVOXFISA-N 0.000 claims 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 2
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 claims 2
- 102000013275 Somatomedins Human genes 0.000 claims 2
- 239000006035 Tryptophane Substances 0.000 claims 2
- 229930003756 Vitamin B7 Natural products 0.000 claims 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 229910000397 disodium phosphate Inorganic materials 0.000 claims 2
- 235000019800 disodium phosphate Nutrition 0.000 claims 2
- 229960002989 glutamic acid Drugs 0.000 claims 2
- 229960004232 linoleic acid Drugs 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 229940045641 monobasic sodium phosphate Drugs 0.000 claims 2
- 235000016709 nutrition Nutrition 0.000 claims 2
- 230000035764 nutrition Effects 0.000 claims 2
- 239000003921 oil Substances 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 238000010008 shearing Methods 0.000 claims 2
- 229960004799 tryptophan Drugs 0.000 claims 2
- 235000011912 vitamin B7 Nutrition 0.000 claims 2
- 239000011735 vitamin B7 Substances 0.000 claims 2
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 claims 1
- 241000699802 Cricetulus griseus Species 0.000 claims 1
- 102000003425 Tyrosinase Human genes 0.000 claims 1
- 108060008724 Tyrosinase Proteins 0.000 claims 1
- CMNWUCGLNTVCSI-UHFFFAOYSA-J [Na+].[Na+].[Na+].[Na+].[Cl-].[O-]P([O-])([O-])=O Chemical compound [Na+].[Na+].[Na+].[Na+].[Cl-].[O-]P([O-])([O-])=O CMNWUCGLNTVCSI-UHFFFAOYSA-J 0.000 claims 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims 1
- 229960002449 glycine Drugs 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- 102000004338 Transferrin Human genes 0.000 abstract description 11
- 108090000901 Transferrin Proteins 0.000 abstract description 11
- 239000012581 transferrin Substances 0.000 abstract description 11
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract description 8
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract description 8
- 230000012010 growth Effects 0.000 abstract description 8
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 239000003102 growth factor Substances 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 230000006978 adaptation Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000008092 positive effect Effects 0.000 abstract description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 abstract 1
- 239000003223 protective agent Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 28
- 239000002609 medium Substances 0.000 description 19
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 18
- 239000012679 serum free medium Substances 0.000 description 12
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 102000004877 Insulin Human genes 0.000 description 9
- 108090001061 Insulin Proteins 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 229940125396 insulin Drugs 0.000 description 9
- 235000002639 sodium chloride Nutrition 0.000 description 8
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 8
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 210000004962 mammalian cell Anatomy 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 229960003495 thiamine Drugs 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 235000020778 linoleic acid Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 229940054269 sodium pyruvate Drugs 0.000 description 4
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 235000009582 asparagine Nutrition 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000003026 cod liver oil Substances 0.000 description 3
- 235000012716 cod liver oil Nutrition 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 3
- 235000019799 monosodium phosphate Nutrition 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 239000011814 protection agent Substances 0.000 description 3
- 239000004017 serum-free culture medium Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229910016870 Fe(NO3)3-9H2O Inorganic materials 0.000 description 2
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 229920001993 poloxamer 188 Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FVXDQWZBHIXIEJ-LNDKUQBDSA-N 1,2-di-[(9Z,12Z)-octadecadienoyl]-sn-glycero-3-phosphocholine Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC FVXDQWZBHIXIEJ-LNDKUQBDSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FICJPXBVKRHEDD-UHFFFAOYSA-N C(C(O)C)(=O)O.[S] Chemical compound C(C(O)C)(=O)O.[S] FICJPXBVKRHEDD-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000009668 clonal growth Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940125645 monoclonal antibody drug Drugs 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【技术领域】【Technical field】
本发明涉及现代生物技术之培养基研发技术领域,具体地说,是一种适于动物细胞大规模培养及抗体、融合蛋白等重组蛋白药物产品生产的无动物来源低蛋白培养基。The invention relates to the technical field of culture medium research and development of modern biotechnology, in particular, it is an animal-free low-protein culture medium suitable for large-scale cultivation of animal cells and production of recombinant protein pharmaceutical products such as antibodies and fusion proteins.
【技术背景】【technical background】
动物细胞培养技术是当今生物工程领域中的前沿课题之一,无论是基础研究还是生产实践方面都得到生物技术界的重视。2000年以来,FDA批准的所有创新生物技术药物中,用酵母表达的只有2种,用大肠杆菌表达的只有6种,而用哺乳动物细胞表达或生产的药物达到55种,占70%以上。2003年6月~2004年6月全球销售额最高的10个生物技术药物中,哺乳动物细胞表达的产品占8个,并且年销售额超过20亿美元的前6位的生物技术药物全部是哺乳动物细胞表达的产品。2005年全球生物技术药物销售额超过500亿美元,哺乳动物细胞表达产品占70%。至2007年末,仅单克隆抗体药物的销售额就达到260亿美元,预计至2013年其销售额将达到490亿美元。应用无血清培养技术进行动物细胞的规模化培养及重组蛋白表达生产已成为一种趋势。Animal cell culture technology is one of the frontier topics in the field of bioengineering today, and has been valued by the biotechnology community in both basic research and production practice. Since 2000, among all the innovative biotechnology drugs approved by the FDA, only 2 were expressed in yeast, only 6 were expressed in Escherichia coli, and 55 were expressed or produced in mammalian cells, accounting for more than 70%. From June 2003 to June 2004, among the top 10 biotechnological drugs with the highest global sales, 8 products expressed in mammalian cells accounted for 8, and the top 6 biotechnological drugs with annual sales of more than 2 billion US dollars were all breast-feeding Products expressed in animal cells. In 2005, the global biotechnology drug sales exceeded 50 billion US dollars, and mammalian cell expression products accounted for 70%. By the end of 2007, the sales of monoclonal antibody drugs alone reached 26 billion U.S. dollars, and its sales are expected to reach 49 billion U.S. dollars by 2013. It has become a trend to apply serum-free culture technology to large-scale culture of animal cells and expression and production of recombinant proteins.
随着哺乳动物细胞培养规模的扩大和生物药物需求的增长,基于细胞及产品特性的无血清培养基的研制已成为细胞工程领域的重要课题。在疫苗生产、单克隆抗体和各种生物活性蛋白等生物制品的应用领域中,优化无血清培养基的成分,使工程细胞在最有利于其生长和目的产物表达的培养环境中维持较高的活细胞密度和较长的培养时间,是降低生产成本的有效方法。With the expansion of the scale of mammalian cell culture and the growth of demand for biopharmaceuticals, the development of serum-free medium based on the characteristics of cells and products has become an important topic in the field of cell engineering. In the field of application of biological products such as vaccine production, monoclonal antibodies and various biologically active proteins, optimize the composition of serum-free medium, so that engineered cells can maintain a high level in the culture environment that is most conducive to their growth and target product expression Viable cell density and longer culture time are effective ways to reduce production costs.
与传统的有血清培养基相比,无血清培养基具有诸多优势:第一,无批次差异、无不明血清组分对细胞的影响;第二,避免了血清中外源性污染及对细胞的毒害作用;第三,使产品易于纯化,提高回收率;第四,成分明确,有利于研究细胞的生理状态,可根据不同细胞株设计和优化能支持其高密度培养和产物高水平表达的培养基。此外,无血清培养技术也是进行细胞生长、增殖、分化及基因表达调控等基础研究的关键技术之一。Compared with traditional serum-containing medium, serum-free medium has many advantages: first, there is no batch difference and no influence of unknown serum components on cells; second, exogenous contamination in serum and damage to cells are avoided. Toxic effect; third, it makes the product easy to purify and improves the recovery rate; fourth, the composition is clear, which is conducive to the study of the physiological state of the cell, and can design and optimize the culture that can support its high-density culture and high-level expression of the product according to different cell lines base. In addition, serum-free culture technology is also one of the key technologies for basic research on cell growth, proliferation, differentiation and gene expression regulation.
无血清培养基的开发与优化,主要有以下两个发展方向:一是不添加任何动物来源的成分;二是降低培养基的蛋白质含量。据此,无血清培养基可以分为以下三种:The development and optimization of serum-free medium mainly has the following two development directions: one is not to add any animal-derived components; the other is to reduce the protein content of the medium. Accordingly, serum-free media can be divided into the following three types:
(一)传统的无血清培养基,即用各类可替代血清功能的组分配制而成,如添加牛血清白蛋白(BSA)、转铁蛋白、胰岛素、从血清中提取的混合脂类及水解蛋白等组分,其特点是蛋白含量高,含有大量动物来源蛋白。(1) Traditional serum-free medium, which is formulated with various components that can replace serum functions, such as adding bovine serum albumin (BSA), transferrin, insulin, mixed lipids extracted from serum, and Components such as hydrolyzed protein are characterized by high protein content and contain a large amount of animal-derived protein.
(二)无动物来源成分的培养基,即祛除培养基中的动物来源成分。由于动物来源成分中可能含有潜在的朊蛋白和病毒污染的危险,因此,在培养基中必须慎用动物来源成分,这样才可确保生产的重组蛋白安全可靠。(2) Medium without animal-derived components, that is, to eliminate animal-derived components in the medium. Due to the potential risk of prions and viral contamination in animal-derived components, animal-derived components must be used with caution in culture media to ensure safe and reliable production of recombinant proteins.
(三)低蛋白或无蛋白培养基,即减少或祛除培养基中蛋白质成分。降低培养基中的蛋白质含量,可减少产物的分离纯化步骤,提高目标蛋白的回收率和品质,保证批次间的一致性,从而实现整个生产过程的高效率和经济性。(3) Low-protein or protein-free medium, that is, to reduce or eliminate protein components in the medium. Reducing the protein content in the medium can reduce the separation and purification steps of the product, improve the recovery rate and quality of the target protein, and ensure the consistency between batches, so as to achieve high efficiency and economy in the entire production process.
综上所述,动物细胞无血清培养基的开发与优化是朝着“无动物来源、无蛋白”的方向发展的。To sum up, the development and optimization of animal cell serum-free medium is moving in the direction of "no animal source, no protein".
经过几十年的发展,哺乳动物细胞〔如杂交瘤、中国仓鼠卵巢细胞(CHO)、NSO等〕无血清培养基技术已取得了可喜的进展:After decades of development, mammalian cell (such as hybridoma, Chinese hamster ovary cell (CHO), NSO, etc.) serum-free medium technology has made gratifying progress:
Darfler等人开发了CITTL无血清培养基,以DMEM/F12(1∶1)为基础培养基,添加了5mg/L的过氧化氢酶、1.5mg/L的胰岛素、1.5~3.0mg/L的转铁蛋白、2nmol/L睾酮、0.5mg/L的二亚油酰磷脂胆碱和1.5mg/L的β-甘油磷酸,可支持sf9细胞的克隆化生长,也可用于杂交瘤细胞的培养。Darfler et al. developed the CITTL serum-free medium, which was based on DMEM/F12 (1:1), added 5 mg/L catalase, 1.5 mg/L insulin, 1.5-3.0 mg/L insulin Transferrin, 2nmol/L testosterone, 0.5mg/L dilinoleoylphosphatidylcholine and 1.5mg/L β-glycerophosphate can support the clonal growth of sf9 cells and can also be used for the culture of hybridoma cells.
Murakami等人开发了无血清培养基,以DMEM/F12(1∶1)为基础培养基,添加了5mg/L胰岛素、2~35mg/L转铁蛋白、20μmol/L乙醇胺和1nmol/L亚硒酸钠等物质,这就是现被广泛使用的DMEM/F12-ITES配方。Murakami et al. developed a serum-free medium based on DMEM/F12 (1:1), supplemented with 5 mg/L insulin, 2-35 mg/L transferrin, 20 μmol/L ethanolamine and 1 nmol/L selenite Sodium acid and other substances, this is the widely used DMEM/F12-ITES formula.
Kover和Frank开发了无血清培养基,以RPMI1640为基础培养基,并添加10mg/L胰岛素、5mg/L转铁蛋白、20μmol/L乙醇胺、5mg/L亚油酸、1g/L牛血清蛋白、3mg/L抗坏血酸、2μg氢化可的松和12种微量元素,可支持几种细胞的生长。Kover and Frank developed a serum-free medium based on RPMI1640, and added 10mg/L insulin, 5mg/L transferrin, 20μmol/L ethanolamine, 5mg/L linoleic acid, 1g/L bovine serum albumin, 3mg/L ascorbic acid, 2μg hydrocortisone and 12 kinds of trace elements can support the growth of several kinds of cells.
美国专利U.S.P.4927762公开了一种含有抗氧化剂的培养基,阐述了细胞在还原性介质中能更好地生长,同时指出,N-乙酰半胱氨酸、硫乳酸、巯基乙醇等物质的添加可以起到抗氧化的作用。U.S. Patent U.S.P.4927762 discloses a culture medium containing antioxidants, which states that cells can grow better in reducing media, and points out that the addition of substances such as N-acetylcysteine, sulfur lactic acid, and mercaptoethanol can Play an antioxidant role.
美国专利U.S.P.4767704主要就微量元素的添加进行了研究,通过对铜、铁、镁、锌、硅、锰、钒、镍、锡、铝、钙、溴、氯、碘、硒、锗等元素和孕酮、腐胺、油酸、嘧啶等物质的添加,开发出了一种无蛋白培养基,使人们认识到微量元素的重要性。U.S. Patent U.S.P.4767704 mainly studies the addition of trace elements, through the analysis of copper, iron, magnesium, zinc, silicon, manganese, vanadium, nickel, tin, aluminum, calcium, bromine, chlorine, iodine, selenium, germanium and other elements and The addition of progesterone, putrescine, oleic acid, pyrimidine and other substances has developed a protein-free medium, making people aware of the importance of trace elements.
Jinyou Zhang等人以Fe-Na2SeO4混合物替代转铁蛋白,研制出的卵巢细胞(CHO)无蛋白培养基能支持较高的活细胞密度。但Fe-Na2SeO4混合物的配制十分复杂,条件苛刻,不适用于规模化生产。Jinyou Zhang et al. replaced transferrin with Fe-Na 2 SeO 4 mixture, and developed a protein-free medium for ovarian cells (CHO) that can support a higher density of viable cells. However, the preparation of the Fe-Na 2 SeO 4 mixture is very complicated and the conditions are harsh, so it is not suitable for large-scale production.
目前,以Gibico,Hyclone、JRH等为代表的商业无血清、无蛋白培养基也已相继问世。在已有的无血清培养基中,有些无法实现高密度培养过程;有些虽能很好地支持细胞生长,但可能导致细胞表达产物能力降低,甚至丧失;此外,商业无血清培养基的配方常属商业机密,且组分复杂、价格昂贵,既不利于特定细胞株培养技术的研究,也无法直接用于细胞培养过程的研究、开发和优化。At present, commercial serum-free and protein-free media represented by Gibico, Hyclone, JRH, etc. have also come out one after another. In the existing serum-free medium, some cannot achieve high-density culture process; although some can support cell growth well, it may lead to the reduction or even loss of the ability of cells to express products; in addition, the formula of commercial serum-free medium is often It is a commercial secret, and its components are complex and expensive, which is not conducive to the research of specific cell line culture technology, nor can it be directly used in the research, development and optimization of cell culture process.
【发明内容】【Content of invention】
本发明的目的在于克服现有技术的不足,提供一种适于动物细胞产品生产的无动物来源低蛋白培养基,以适应动物细胞大规模培养及工业生产重组蛋白药物产品的需要。The purpose of the present invention is to overcome the deficiencies of the prior art and provide an animal-free low-protein medium suitable for the production of animal cell products to meet the needs of large-scale cultivation of animal cells and industrial production of recombinant protein pharmaceutical products.
为实现上述目的,本发明采取的技术方案为:In order to achieve the above object, the technical scheme that the present invention takes is:
一种适于动物细胞产品生产的无动物来源低蛋白培养基,其特征是,采用大豆水解物替代动物来源成分(如,牛血清白蛋白等),采用硫酸亚铁、硝酸铁和EDTA·2Na的组合物替代转铁蛋白,其成分包括基础代谢营养物类、维生素类、转铁蛋白替代物、脂类、核酸类、激素及生长因子类、抗氧化剂类、抗剪切保护剂、pH指示剂、pH缓冲剂和其他无机盐类;A kind of non-animal-derived low-protein medium suitable for the production of animal cell products is characterized in that soybean hydrolyzate is used to replace animal-derived components (such as bovine serum albumin, etc.), and ferrous sulfate, ferric nitrate and EDTA·2Na are used The composition replaces transferrin, and its composition includes basic metabolic nutrients, vitamins, transferrin substitutes, lipids, nucleic acids, hormones and growth factors, antioxidants, anti-shear protection agents, pH indicators Agents, pH buffers and other inorganic salts;
——所述的基础代谢营养物类包括:葡萄糖、大豆水解物、丙酮酸钠、谷氨酰胺、丙氨酸、精氨酸、天冬酰胺、天冬氨酸、半胱氨酸、胱氨酸、谷氨酸、甘氨酸、组氨酸、异亮氨酸、亮氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、脯氨酸、丝氨酸、苏氨酸、色氨酸、酪氨酸、缬氨酸;——The basal metabolic nutrients include: glucose, soybean hydrolyzate, sodium pyruvate, glutamine, alanine, arginine, asparagine, aspartic acid, cysteine, cystine Acid, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine amino acid, valine;
——所述的维生素类包括:生物素、维生素、氯化胆碱、叶酸、肌醇、烟酰胺、泛酸钙、维生素B6、核黄素、维生素B1、硫辛酸;——The vitamins include: biotin, vitamins, choline chloride, folic acid, inositol, nicotinamide, calcium pantothenate, vitamin B6, riboflavin, vitamin B1, lipoic acid;
——所述的转铁蛋白替代物类包括:硫酸亚铁、硝酸铁、EDTA·2Na;——The transferrin substitutes include: ferrous sulfate, ferric nitrate, EDTA·2Na;
——所述的脂类包括:乙醇胺、吐温80、鱼肝油、胆固醇、亚油酸;——The lipids include: ethanolamine, Tween 80, cod liver oil, cholesterol, linoleic acid;
——所述的核酸类包括:胸苷、次黄嘌呤;——The nucleic acids include: thymidine, hypoxanthine;
——所述的激素及生长因子类包括:孕酮、氢化可的松、重组胰岛素、腐胺;——The hormones and growth factors include: progesterone, hydrocortisone, recombinant insulin, putrescine;
——所述的抗氧化剂类包括:亚硒酸钠、生育酚、牛磺酸;- the antioxidants include: sodium selenite, tocopherol, taurine;
——所述的抗剪切保护剂为嵌段式聚醚F68;——The anti-shear protection agent is block polyether F68;
——所述的pH指示剂为酚红;- the pH indicator is phenol red;
——所述的pH缓冲剂包括碳酸氢钠、Hepes;- the pH buffer comprises sodium bicarbonate, Hepes;
——所述的其他无机盐类包括:氯化钙、氯化镁、硫酸镁、氯化钾、磷酸二氢钠、氯化钠、磷酸氢二钠、硫酸锌、硫酸铜。——The other inorganic salts mentioned include: calcium chloride, magnesium chloride, magnesium sulfate, potassium chloride, sodium dihydrogen phosphate, sodium chloride, disodium hydrogen phosphate, zinc sulfate, copper sulfate.
一种适于动物细胞产品生产的无动物来源低蛋白培养基,其各种成分的含量为(毫克/升):A kind of animal-source-free low-protein medium suitable for the production of animal cell products, the content of its various components is (mg/L):
葡萄糖(D-Glucose) 2000~7000Glucose ( D -Glucose) 2000~7000
大豆水解物(Lucratone Soy) 500~1000Soybean hydrolyzate (Lucratone Soy) 500~1000
丙酮酸钠(Sodium Pyruvate) 55~220Sodium Pyruvate (Sodium Pyruvate) 55~220
谷氨酰胺(L-Glutamine) 200~900Glutamine ( L -Glutamine) 200~900
丙氨酸(L-Alanine) 4~15Alanine ( L -Alanine) 4~15
精氨酸(L-Arginine·HCl) 100~300Arginine ( L -Arginine·HCl) 100~300
天冬酰胺(L-Asparagine·H2O) 6~15Asparagine ( L -Asparagine·H 2 O) 6~15
天冬氨酸(L-Aspartic Acid) 6~15Aspartic acid ( L -Aspartic Acid) 6~15
半胱氨酸(L-Cysteine·H2O) 15~50Cysteine ( L -Cysteine·H 2 O) 15~50
胱氨酸(L-Cystine·2HCl) 30~65Cystine ( L -Cystine·2HCl) 30~65
谷氨酸(L-Glutamic Acid) 5~20Glutamic acid ( L -Glutamic Acid) 5~20
甘氨酸(Glycine) 15~40
组氨酸(L-Histidine·HCl·H2O) 15~40Histidine ( L -Histidine·HCl·H 2 O) 15~40
异亮氨酸(L-Isoleucine) 50~100Isoleucine ( L -Isoleucine) 50~100
亮氨酸(L-Leucine) 50~150Leucine ( L -Leucine) 50~150
赖氨酸(L-Lysine·HCl) 80~185Lysine ( L -Lysine·HCl) 80~185
甲硫氨酸(L-Methionine) 15~35Methionine ( L -Methionine) 15~35
苯丙氨酸(L-Phenyalanine) 30~70Phenylalanine ( L -Phenyalanine) 30~70
脯氨酸(L-Proline) 10~34.5Proline ( L -Proline) 10~34.5
丝氨酸(L-Serine) 20~52.5Serine ( L -Serine) 20~52.5
苏氨酸(L-Threonine) 50~107Threonine ( L -Threonine) 50~107
色氨酸(L-Tryptophan) 9~18Tryptophan ( L -Tryptophan) 9~18
酪氨酸(L-Tyrosine·2Na·2H2O) 55~120Tyrosine ( L -Tyrosine·2Na·2H 2 O) 55~120
缬氨酸(L-Valine) 50~120Valine ( L -Valine) 50~120
生物素(Biotin) 0.0035~0.0105Biotin 0.0035~0.0105
维生素B12(Vitamin B12) 0.50~2.50Vitamin B12 (Vitamin B12) 0.50~2.50
氯化胆碱(Choline Chloride) 8.50~30Choline Chloride 8.50~30
叶酸(Folic acid) 2.50~8Folic acid 2.50~8
肌醇(I-Nositol) 12~30Inositol ( I -Nositol) 12~30
烟酰胺(Niacinamide) 2~7Niacinamide 2~7
泛酸钙(D-Ca·Pantothenate) 2~8Calcium pantothenate ( D -Ca·Pantothenate) 2~8
维生素B6(Pyridoxine·HCl) 2~8Vitamin B6 (Pyridoxine·HCl) 2~8
核黄素(Riboflavin) 0.2~0.7Riboflavin 0.2~0.7
维生素B1(Thiamine·HCl) 2~8Vitamin B1 (Thiamine·HCl) 2~8
硫辛酸(Lipoic acid) 0.08~0.50Lipoic acid 0.08~0.50
硫酸亚铁(FeSO4·7H2O) 0.417~5Ferrous sulfate (FeSO 4 7H 2 O) 0.417~5
硝酸铁(Fe(NO3)3·9H2O) 0.05~0.8Iron nitrate (Fe(NO 3 ) 3 9H 2 O) 0.05~0.8
EDTA·2Na 2~10EDTA·2Na 2~10
乙醇胺(Ethanolamine) 3~10Ethanolamine 3~10
吐温80(Tween 80) 0.24~0.5Tween 80 (Tween 80) 0.24~0.5
鱼肝油(Cod liver oil) 0.1~0.2Cod liver oil 0.1~0.2
胆固醇(Cholesterol) 0.045~0.1Cholesterol 0.045~0.1
亚油酸(Linoleic acid) 0.042~0.084Linoleic acid (Linoleic acid) 0.042~0.084
胸苷(Thymidine) 0.4~2.5Thymidine 0.4~2.5
次黄嘌呤(Hypoxanthine) 2~20Hypoxanthine 2~20
孕酮(Progesterone) 0.003~0.012Progesterone 0.003~0.012
氢化可的松(Hydrocortisone·HCl) 0.036~0.072Hydrocortisone (Hydrocortisone·HCl) 0.036~0.072
重组胰岛素(Insulin) 3~8Recombinant insulin (Insulin) 3~8
腐胺(Sodium Putrescine·HCl) 0.08~20Putrescine (Sodium Putrescine·HCl) 0.08~20
亚硒酸钠(Sodium Selenate) 0.02~0.08Sodium Selenite (Sodium Selenate) 0.02~0.08
生育酚(α-Tocohcrol acetate) 1~4Tocopherol (α-Tocohcrol acetate) 1~4
牛磺酸(Taurin) 20~50
嵌段式聚醚F68(Pluronic-F68) 500~2000Block polyether F68 (Pluronic-F68) 500~2000
酚红(Phenol Red) 8.1Phenol Red 8.1
碳酸氢钠(NaHCO3) 2450Sodium bicarbonate (NaHCO 3 ) 2450
Hepes 2000~5000Hepes 2000~5000
氯化钙(CaCl2) 110~150Calcium chloride (CaCl 2 ) 110~150
氯化镁(MgCl2) 40~75Magnesium chloride (MgCl 2 ) 40~75
硫酸镁(MgSO4) 45~65Magnesium sulfate (MgSO 4 ) 45~65
氯化钾(KCl) 310~400Potassium chloride (KCl) 310~400
磷酸二氢钠(NaH2PO4·H2O) 60~120Sodium dihydrogen phosphate (NaH 2 PO 4 ·H 2 O) 60~120
氯化钠(NaCl) 6995.5Sodium chloride (NaCl) 6995.5
磷酸氢二钠(Na2HPO4) 55~120Disodium hydrogen phosphate (Na 2 HPO 4 ) 55~120
硫酸锌(ZnSO4·7H2O) 0.432~1.25Zinc sulfate (ZnSO 4 7H 2 O) 0.432~1.25
硫酸铜(CuSO4·5H2O) 0.0013~0.0065。Copper sulfate (CuSO 4 ·5H 2 O) 0.0013~0.0065.
本发明的积极效果是:The positive effect of the present invention is:
(1)不含动物来源成分,总蛋白含量低于10毫克/升,有利于产物的分离纯化,适于动物细胞表达的重组蛋白类药物产品生产,安全可靠。(1) It does not contain animal-derived components, and the total protein content is less than 10 mg/L, which is conducive to the separation and purification of products, and is suitable for the production of recombinant protein pharmaceutical products expressed in animal cells, which is safe and reliable.
(2)支持动物细胞的正常生长、重组蛋白表达和长期传代培养,无需适应即可使用,其最高活细胞密度及重组蛋白产量均超过已知的商业培养基。(2) It supports normal growth of animal cells, recombinant protein expression and long-term subculture, and can be used without adaptation, and its highest living cell density and recombinant protein production exceed known commercial media.
(3)成分简单,配制方便,适合于动物细胞产品的大规模生产。(3) The composition is simple, the preparation is convenient, and it is suitable for large-scale production of animal cell products.
【附图说明】【Description of drawings】
附图为CHO细胞在本发明的无动物来源低蛋白培养基中批培养生长和产物表达曲线的坐标图。The accompanying drawing is a coordinate diagram of the growth and product expression curves of batch culture of CHO cells in the animal-source-free low-protein medium of the present invention.
【具体实施方式】【Detailed ways】
以下对本发明适于动物细胞产品生产的无动物来源低蛋白培养基的实施例进行具体说明,但本发明不限于以下的实施方式。The examples of the animal-source-free low-protein medium suitable for the production of animal cell products of the present invention are described in detail below, but the present invention is not limited to the following embodiments.
一种适于动物细胞产品生产的无动物来源低蛋白培养基,包括24种基础代谢营养物、11种维生素、3种转铁蛋白替代物类化合物、5种脂类化合物、2种核酸类化合物、4种激素及生长因子、3种抗氧化剂、1种抗剪切保护剂、1种pH指示剂、2种pH缓冲剂、9种其他无机盐,各种成分的含量为(毫克/升):An animal-source-free low-protein medium suitable for the production of animal cell products, including 24 basic metabolic nutrients, 11 vitamins, 3 transferrin substitute compounds, 5 lipid compounds, and 2 nucleic acid compounds , 4 kinds of hormones and growth factors, 3 kinds of antioxidants, 1 kind of anti-shear protection agent, 1 kind of pH indicator, 2 kinds of pH buffering agents, 9 kinds of other inorganic salts, the content of each component is (mg/L) :
葡萄糖(D-Glucose) 4500Glucose ( D -Glucose) 4500
大豆水解物(Lucratone Soy) 1000Soybean hydrolyzate (Lucratone Soy) 1000
丙酮酸钠(Sodium Pyruvate) 55Sodium Pyruvate 55
谷氨酰胺(L-Glutamine) 584.6Glutamine ( L -Glutamine) 584.6
丙氨酸(L-Alanine) 5Alanine ( L -Alanine) 5
精氨酸(L-Arginine·HCl) 155Arginine ( L -Arginine·HCl) 155
天冬酰胺(L-Asparagine·H2O) 7.5Asparagine ( L -Asparagine·H 2 O) 7.5
天冬氨酸(L-Aspartic Acid) 6.65Aspartic acid ( L -Aspartic Acid) 6.65
半胱氨酸(L-Cysteine·H2O) 17.56Cysteine ( L -Cysteine·H 2 O) 17.56
胱氨酸(L-Cystine·2HCl) 31.29Cystine ( L -Cystine·2HCl) 31.29
谷氨酸(L-Glutamic Acid) 7.35Glutamic Acid ( L -Glutamic Acid) 7.35
甘氨酸(Glycine) 18.75Glycine 18.75
组氨酸(L-Histidine·HCl·H2O) 18.75Histidine ( L -Histidine·HCl·H 2 O) 18.75
异亮氨酸(L-Isoleucine) 54.47Isoleucine ( L -Isoleucine) 54.47
亮氨酸(L-Leucine) 59.05Leucine ( L -Leucine) 59.05
赖氨酸(L-Lysine·HCl) 91.25Lysine ( L -Lysine·HCl) 91.25
甲硫氨酸(L-Methionine) 17.24Methionine ( L -Methionine) 17.24
苯丙氨酸(L-Phenyalanine) 35.48Phenylalanine ( L -Phenyalanine) 35.48
脯氨酸(L-Proline) 17.25Proline ( L -Proline) 17.25
丝氨酸(L-Serine) 26.25Serine ( L -Serine) 26.25
苏氨酸(L-Threonine) 53.45Threonine ( L -Threonine) 53.45
色氨酸(L-Tryptophan) 9.02Tryptophan ( L -Tryptophan) 9.02
酪氨酸(L-Tyrosine·2Na·2H2O) 55.79Tyrosine ( L -Tyrosine·2Na·2H 2 O) 55.79
缬氨酸(L-Valine) 52.85Valine ( L -Valine) 52.85
生物素(Biotin) 0.0105Biotin 0.0105
维生素B12(Vitamin B12) 2.04Vitamin B12 (Vitamin B12) 2.04
氯化胆碱(Choline Chloride) 26.94Choline Chloride 26.94
叶酸(Folic acid) 7.95Folic acid 7.95
肌醇(I-Nositol) 12.6Inositol ( I -Nositol) 12.6
烟酰胺(Niacinamide) 6.06Niacinamide 6.06
泛酸钙(D-Ca·Pantothenate) 6.72Calcium pantothenate ( D -Ca Pantothenate) 6.72
维生素B6(Pyridoxine·HCl) 6.093Vitamin B6 (Pyridoxine·HCl) 6.093
核黄素(Riboflavin) 0.657Riboflavin 0.657
维生素B1(Thiamine·HCl) 6.51Vitamin B1 (Thiamine·HCl) 6.51
硫辛酸(Lipoic acid) 0.305Lipoic acid 0.305
硫酸亚铁(FeSO4·7H2O) 1.217Ferrous sulfate (FeSO 4 7H 2 O) 1.217
硝酸铁(Fe(NO3)3·9H2O) 0.65Iron nitrate (Fe(NO 3 ) 3 9H 2 O) 0.65
EDTA·2Na 5EDTA·
乙醇胺(Ethanolamine) 9Ethanolamine 9
吐温80(Tween 80) 0.24Tween 80 (Tween 80) 0.24
鱼肝油(Cod liver oil) 0.1Cod liver oil 0.1
胆固醇(Cholesterol) 0.045Cholesterol 0.045
亚油酸(Linoleic acid) 0.042Linoleic acid 0.042
胸苷(Thymidine) 2.365Thymidine 2.365
次黄嘌呤(Hypoxanthine) 10
孕酮(Progesterone) 0.006Progesterone 0.006
氢化可的松(Hydrocortisone·HCl) 0.036Hydrocortisone (Hydrocortisone·HCl) 0.036
胰岛素(Insulin) 8Insulin 8
腐胺(Sodium Putrescine·HCl) 0.081Putrescine (Sodium Putrescine·HCl) 0.081
亚硒酸钠(Sodium Selenate) 0.0519Sodium Selenite 0.0519
黄体酮(α-Tocohcrol acetate) 2Progesterone (α-Tocohcrol acetate) 2
牛磺酸(Taurin) 30
嵌段式聚醚F68(Pluronic-F68) 1000Block polyether F68 (Pluronic-F68) 1000
酚红(Phenol Red) 8.1Phenol Red 8.1
碳酸氢钠(NaHCO3) 2450Sodium bicarbonate (NaHCO 3 ) 2450
Hepes 3500Hepes 3500
氯化钙(CaCl2) 116.6Calcium chloride (CaCl 2 ) 116.6
氯化镁(MgCl2) 40.4Magnesium chloride (MgCl 2 ) 40.4
硫酸镁(MgSO4) 48.84Magnesium sulfate (MgSO 4 ) 48.84
氯化钾(KCl) 311.8Potassium chloride (KCl) 311.8
磷酸二氢钠(NaH2PO4·H2O) 120Sodium dihydrogen phosphate (NaH 2 PO 4 ·H 2 O) 120
氯化钠(NaCl) 6995.5Sodium chloride (NaCl) 6995.5
磷酸氢二钠(Na2HPO4) 110Disodium hydrogen phosphate (Na 2 HPO 4 ) 110
硫酸铜(CuSO4·5H2O) 0.006Copper sulfate (CuSO 4 5H 2 O) 0.006
硫酸锌(ZnSO4·7H2O) 0.432。Zinc sulfate (ZnSO 4 ·7H 2 O) 0.432.
将上述组分溶解于三次蒸馏水中,即可配制成适于动物细胞产品生产的无动物来源低蛋白培养基。Dissolving the above components in triple distilled water can be prepared into an animal-source-free low-protein medium suitable for the production of animal cell products.
使用本发明所述的无动物来源低蛋白培养基,将表达抗CD20嵌合单克隆抗体的中国仓鼠卵巢细胞(CHO)接种于2升生物反应器中,接种密度为2.39×105细胞/毫升,接种时细胞活性为98.45%;细胞在此2升反应器中进行155小时的批培养,对数生长期的平均比生长速率为0.652天-1,最大活细胞密度达3.75×106细胞/毫升,细胞扩增15.7倍,最大单抗浓度为203毫克/升,活细胞密度对时间的积分值为13.41×109细胞·天,对数生长期单位细胞每天的抗体产量达15.88毫克/109细胞·天。Chinese hamster ovary cells (CHO) expressing anti-CD20 chimeric monoclonal antibody were inoculated in a 2-liter bioreactor with an inoculation density of 2.39×10 5 cells/ml using the animal-derived low-protein medium of the present invention , the cell viability was 98.45% at the time of inoculation; the cells were batch cultured in this 2-liter reactor for 155 hours, the average specific growth rate in the logarithmic growth phase was 0.652 days -1 , and the maximum viable cell density reached 3.75×10 6 cells/ ml, cell expansion was 15.7 times, the maximum monoclonal antibody concentration was 203 mg/L, the integral value of viable cell density versus time was 13.41×10 9 cells per day, and the daily antibody output per unit cell in the logarithmic growth phase reached 15.88 mg/10 9 cells · day.
附图为CHO细胞在本发明的无动物来源低蛋白培养基中批培养生长和产物表达曲线的坐标图,附中,Accompanying drawing is the coordinate diagram of CHO cell batch culture growth and product expression curve in the animal-free low-protein medium of the present invention, attached middle,
◆活细胞曲线;◆Live cell curve;
■死细胞曲线;■ dead cell curve;
▲总细胞曲线;▲Total cell curve;
□产物曲线。□ Product curve.
从附图的曲线可以得知,本发明适于动物细胞产品生产的无动物来源低蛋白培养基能良好地支持细胞的正常生长和产物表达,其最高活细胞密度及产物浓度均超过已知的商业培养基。As can be seen from the curve of the accompanying drawing, the animal-free low-protein medium suitable for the production of animal cell products of the present invention can well support the normal growth of cells and product expression, and its highest viable cell density and product concentration all exceed known commercial media.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100535068A CN101603026B (en) | 2009-06-19 | 2009-06-19 | Animal-source-free low-protein medium suitable for production of animal cell products |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100535068A CN101603026B (en) | 2009-06-19 | 2009-06-19 | Animal-source-free low-protein medium suitable for production of animal cell products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101603026A CN101603026A (en) | 2009-12-16 |
| CN101603026B true CN101603026B (en) | 2011-01-19 |
Family
ID=41468927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100535068A Expired - Fee Related CN101603026B (en) | 2009-06-19 | 2009-06-19 | Animal-source-free low-protein medium suitable for production of animal cell products |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101603026B (en) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101984845A (en) * | 2010-09-21 | 2011-03-16 | 中山粤海饲料有限公司 | Low-salinity culture marine fish feed additive premix |
| CN102757939A (en) * | 2010-12-29 | 2012-10-31 | 中山大学 | Tsingtao amphioxus cell line culture fluid and preparation method thereof |
| US11292829B2 (en) * | 2011-07-01 | 2022-04-05 | Amgen Inc. | Mammalian cell culture |
| CN102766662A (en) * | 2012-07-30 | 2012-11-07 | 中粮生物化学(安徽)股份有限公司 | Culture medium and application of culture medium and lysine flask shaking fermentation method |
| US10017732B2 (en) * | 2013-03-15 | 2018-07-10 | Genentech, Inc. | Cell culture compositions with antioxidants and methods for polypeptide production |
| AR095196A1 (en) | 2013-03-15 | 2015-09-30 | Regeneron Pharma | SERUM FREE CELL CULTIVATION MEDIA |
| JP2016513478A (en) * | 2013-03-15 | 2016-05-16 | ジェネンテック, インコーポレイテッド | Cell culture medium and method for producing antibodies |
| WO2015148515A1 (en) | 2014-03-24 | 2015-10-01 | Biogen Ma Inc. | Methods for overcoming glutamine deprivation during mammalian cell culture |
| PE20161326A1 (en) * | 2014-04-10 | 2016-12-11 | Bayer Healthcare Llc | POWDER FORMULATION OF COMPOUND MEDIA AND PREPARATION METHOD OF LIQUID MEDIUM FOR CELL CULTURE |
| CN104232564A (en) * | 2014-05-12 | 2014-12-24 | 杭州国牧生物科技有限公司 | Culture medium suitable for preparing hog cholera vaccines from ST cell and using method thereof |
| CN105255812B (en) * | 2014-07-15 | 2019-03-12 | 内蒙古金源康生物工程有限公司 | Low-serum culture medium suitable for BHK-21 cell spinner flask culture and preparation method thereof |
| CN104130971B (en) * | 2014-08-12 | 2015-03-11 | 山西威奇达光明制药有限公司 | Serum-free medium of recombinant human erythropoietin, applications of serum-free medium and method for preparing recombinant human erythropoietin |
| TWI899515B (en) * | 2015-08-04 | 2025-10-01 | 美商再生元醫藥公司 | Taurine supplemented cell culture medium and methods of use |
| CN105255810A (en) * | 2015-11-09 | 2016-01-20 | 内蒙古金源康生物工程有限公司 | Serum-free and animal-source-free culture medium suitable for insect cell Sf-9 |
| CN105462912B (en) * | 2016-01-21 | 2019-10-22 | 四川百诺吉科技有限公司 | Suitable for diploid cell culture without albumen serum free medium and application |
| CN106754693A (en) * | 2016-12-24 | 2017-05-31 | 严志海 | A kind of animal origin-free low-protein culture medium containing licorice polysaccharide |
| CN106834225A (en) * | 2016-12-24 | 2017-06-13 | 严志海 | A kind of immune cell media |
| CN106834420A (en) * | 2016-12-30 | 2017-06-13 | 河北德路通生物科技有限公司 | Cell cleaning fluid, its preparation method and application with target cell sample defencive function |
| CN110914293B (en) * | 2017-07-06 | 2024-08-13 | 里珍纳龙药品有限公司 | Cell culture processes for the production of glycoproteins |
| CN110484487A (en) * | 2019-08-21 | 2019-11-22 | 安徽欣乐生物技术有限公司 | One kind being suitable for Chinese hamster ovary celI culture protein-free medium and its cultural method |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| CN112442486B (en) * | 2020-11-05 | 2023-02-10 | 上海奥浦迈生物科技股份有限公司 | A kind of culture medium and application thereof for maintaining the viability rate of CHO DG44 cells in vitro |
| CN114645010A (en) * | 2020-12-18 | 2022-06-21 | 南京基蛋生物医药有限公司 | Low-protein serum-free cell culture medium for producing monoclonal antibody and application thereof |
| CN114540274B (en) * | 2022-02-17 | 2023-10-20 | 上海健士拜生物科技有限公司 | Serum-free medium, preparation method thereof and method for culturing 2BS cells by using serum-free medium |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1391604A (en) * | 1999-09-28 | 2003-01-15 | 巴克斯特股份公司 | Media for growing cells protein-free and serum-free |
| WO2005066332A1 (en) * | 2003-12-19 | 2005-07-21 | Wyeth | Serum-free vero cell banking process |
| CN101245335A (en) * | 2008-03-21 | 2008-08-20 | 乐能生物工程股份有限公司 | Non-blood serum plant protein peptide universal cell culture medium |
-
2009
- 2009-06-19 CN CN2009100535068A patent/CN101603026B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1391604A (en) * | 1999-09-28 | 2003-01-15 | 巴克斯特股份公司 | Media for growing cells protein-free and serum-free |
| WO2005066332A1 (en) * | 2003-12-19 | 2005-07-21 | Wyeth | Serum-free vero cell banking process |
| CN101245335A (en) * | 2008-03-21 | 2008-08-20 | 乐能生物工程股份有限公司 | Non-blood serum plant protein peptide universal cell culture medium |
Non-Patent Citations (2)
| Title |
|---|
| 朱宏庆等.MCDB153无血清培养基的优化.《中国生物制品学杂志 》.2005,第18卷(第3期),256-258. * |
| 黄斌等.rCHO 细胞无血清适应及悬浮培养.《华东理工大学学报》.2004,第30卷(第1期),38-42. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101603026A (en) | 2009-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101603026B (en) | Animal-source-free low-protein medium suitable for production of animal cell products | |
| CN101760442B (en) | Serum-free medium for MDCK cell large-scale adherent culture and single-cell suspension culture | |
| CN101418330B (en) | Non protein culture medium adapted to large-scale culture of NSO cell and production of antibody | |
| CN109337861B (en) | CHO cell serum-free medium supporting high expression of product | |
| CN100362098C (en) | Serum-free medium suitable for large-scale culture of various animal cells | |
| CN108949678B (en) | Stem cell culture medium and culture method | |
| CN102827804A (en) | Culture medium applicable to suspension and magnification cultivation of Vero cell microcarriers and method for suspension magnification cultivation of Vero cell microcarriers | |
| CN101724600A (en) | Blood serum-free culture medium for supporting suspension culture of CHO cells with large scale and high density | |
| CN109234223B (en) | Low-protein serum-free cell culture medium | |
| CN111440764A (en) | Serum-free medium for mesenchymal stem cells and clinical scale culture method for mesenchymal stem cells | |
| CN100506977C (en) | A kind of Chinese hamster ovary cell expansion medium and application thereof | |
| CN101974481A (en) | Serum free culture medium for growing various cells derived from kidney tissue | |
| CN107043747A (en) | A kind of human umbilical cord mesenchymal stem cells serum free medium | |
| CN104328158B (en) | Specific chemical components culture medium suitable for the large-scale production of animal cell expression product | |
| CN101195817A (en) | Hybrid tumor cell amplification culture medium and uses thereof | |
| CN106834229A (en) | For the serum free medium of people's immunologic cytotoxicity cell expansion ex vivo | |
| CN102399742A (en) | Serum-free culture fluid for culture of salivary gland epidermal cell and salivary gland stem cell of mammals | |
| CN104593316A (en) | Insect cell serum-free culture medium and application thereof | |
| CN106957815A (en) | A kind of formula of serum free medium for mankind's pluripotent stem cell | |
| CN105543163A (en) | Serum-free culture medium used for full-suspension culture of MDCK (Madin Darby Canine Kidney) cells | |
| CN110004114A (en) | A kind of serum free medium of dental pulp stem cell | |
| CN109370985A (en) | Serum-free medium for large-scale culture of human umbilical cord mesenchymal stem cells | |
| CN100348718C (en) | Culture medium without animal originating component and serum for HEK293 cell adhesion culture | |
| CN105567628B (en) | A kind of low blood serum medium of the full culture mdck cell that suspends | |
| CN102021139A (en) | Chinese hamster ovary culture medium as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110119 |